Review
Version 2
Preserved in Portico This version is not peer-reviewed
An Updated Primer on SARS-CoV-2 and the Evolving Covid-19 Pandemic
Version 1
: Received: 22 April 2020 / Approved: 24 April 2020 / Online: 24 April 2020 (14:15:59 CEST)
Version 2 : Received: 31 May 2020 / Approved: 1 June 2020 / Online: 1 June 2020 (11:08:03 CEST)
Version 2 : Received: 31 May 2020 / Approved: 1 June 2020 / Online: 1 June 2020 (11:08:03 CEST)
How to cite: Mani, S. An Updated Primer on SARS-CoV-2 and the Evolving Covid-19 Pandemic. Preprints 2020, 2020040449. https://doi.org/10.20944/preprints202004.0449.v2 Mani, S. An Updated Primer on SARS-CoV-2 and the Evolving Covid-19 Pandemic. Preprints 2020, 2020040449. https://doi.org/10.20944/preprints202004.0449.v2
Abstract
In this paper we first provide a primer on SARS-CoV-2 and Covid-19 delineating the etiopathogenesis, epidemiology, clinical manifestations and the natural history of the disease. We then trace the evolution of the Covid-19 pandemic highlighting the characteristics of the epidemic in China where the pandemic originated, select countries of Europe which peaked during April, and Brazil, US and India where the pandemic has taken serious turns recently. We also project some possible trajectories for the mega cities of India based on the demographic characteristics of these cities in comparison to New York city. This is an updated version of the article from mid-April published online.
Keywords
SARS-CoV-2; Covid-19; pandemic; primer; India; mortality rate; evolution; updated primer; evolving pandemic
Subject
Public Health and Healthcare, Health Policy and Services
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (1)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
Commenter: Subramani Mani
Commenter's Conflict of Interests: Author
2. SARS-CoV-2 genome figure (Figure 2) newly added.
3. SARS-CoV-2 diagnostic test illustration figure (Figure 4) newly added.
4. Epidemiology and Clinical characteristics extensively revised to reflect the current literature on Covid-19.
5. Two new sections (1) Cutaneious manifestations and (2) Children and Covid-19 added.
6. Sections on Drug pipeline and Vaccine trials revised and updated.
7. Section titled Covid-19 pandemic story so far extensively revised and also includes details of outbreak in Russia and Brazil.
8. The projections for India have also been updated based new data available on the outbreak in India.
9. Conclusion section has also been revised to reflect the above-mentioned revisions.